Could Low Float (JZZI) Be A Cut Above Based On Recent Acquisition Related News? Key Details Now

The human quest to remain young and live forever has long left the realm of fantasy to shake up the world of finance with a series of life-affirming jolts. Could Low Float (JZZI) Be A Cut Above Based On Recent Acquisition Related News? Key Details Now February 2nd Dear Reader, The human quest to remain young and live forever has long left the realm of fantasy to shake up the world of finance with a series of life-affirming jolts. Partly stoked by myths such as the fountain of youth and vampiric regeneration, ambitious startups from Silicon Valley, biotech, and pharma have blazed divergent roadmaps that might soon lead us to prolonged youth, extended lifespans, and immortality. Collectively, these startups form the nascent anti-aging and longevity industry, which is set to reach a market value of $64Bn by 2026 according to [Research & Markets.]( With a host of billionaires and institutional in-vest-ors already bankrolling the industry, a number of standout players have launched pioneering research into how we just might halt the aging process and perhaps even deactivate death itself. And one company I've been tracking closely has been in hot pursuit of acquisition targets that could turn this under-the-radar idea into a major player in this fast-paced growth industry for years to come. Knowing that, there is only one breakout idea to have on your radar for Wednesday, February 2nd: *JZZ Technologies, Inc. (JZZI)* JZZ Technologies, Inc. is a diversified technology company engaged in the following two distinct business sectors: (i) its digital media business, which includes online media and apps (activelifestylemedia(dot)com), content creation, digital marketing, streaming video content, publishing, and free over-the-air television (EyeOnTV) targeted to active adults 55+, and; (ii) strategic biotechnology and bioscience-related to Human Life Extension and Human Longevity that can be immediately leveraged to support improved quality of life for the senior population. And right now, based on these 5 potential catalysts, this profile requires immediate attention: No. 1 - Advancing Research Through Anticipated Venture No. 2 - Huge Acquisition Related News Could Become Game-Changer No. 3 - Signing Of LOI To Start New Business Venture No. 4 - Huge Revenue Projection Moving Forward No. 5 - Another Low Float Idea So let's get to it... No. 1 JZZI Potential Catalyst - Advancing Research Through Anticipated Venture Based on Latest Research, JZZ Technologies, Inc. Announces New Immune Boost and Anti-Inflammatory Products Developed Through Nutrific Inc. New research from GenBio Inc. working with Nutrific Inc. is focused on the body's signaling process to address inflammatory disorders and its reaction to the Cytokine Storm West Palm Beach, Florida--(Newsfile Corp. - December 22, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) is advancing research being forwarded by its anticipated venture with Nutrific, Inc. and GenBio Inc. in order to provide a breakthrough immune boost and anti-inflammatory product line. The new research focuses on the body's negative reaction to viruses,... International research supports that this response is an unnatural reaction that should be treatable through immune boost and anti-inflammatory products. The Nutrific products aim to specifically address the transduction (signaling) process in inflammatory disorders to mitigate the worst effects of a virus and the body's response to them. These two areas represent massive markets where a relevant natural treatment could provide significant revenues through a patented treatment. The global immune health supplements market is projected to grow from $20.18Bn in 2021 to $31.50Bn in 2028 at a CAGR of 6.6% from 2021 to 2028 (source: Fortune Business Insights). Alongside the immune health market, the Global Anti-Inflammatory Therapeutics market size is estimated to grow at CAGR of almost 6% with $27.53Bn during the forecast period 2021-2024 (source: MarketWatch). These are the two markets that Nutrific expects to enter with its new products. [...] [Read the full article here.]( ----- No. 2 JZZI Potential Catalyst - Huge Acquisition Related News Could Become Game-Changer JZZ Technologies, Inc. Signs LOI to Acquire Life Factor Research Inc In its second acquisition in the bioscience and human longevity sector, JZZ Technologies, Inc. intends to acquire Life Factor Research Inc. and begin marketing its unique and patented line of natural supplements West Palm Beach, Florida--(Newsfile Corp. - December 6, 2021) - JZZ Technologies, Inc., (OTC Pink: JZZI) has signed a Letter of Intent ("LOI") with life sciences company Life Factor Research Inc. of Medford, Oregon. Under the terms of the Letter of Intent, dated November 30, 2021, JZZ Technologies, Inc. will acquire 100% ownership of Life Factor Research Inc., its formulations, research, products, and manufacturing operations. [...] Charles Cardona, CEO of JZZ Technologies, Inc., stated, "Life Factor Research's ongoing development of products and research are an excellent fit for our direction in the life extension and biosciences. We also join with Charles Layton, who can bring his vast experience to our team and head up our life sciences and bioscience operations. This adds a huge resource to our company." [...] [Read the full article here.]( ----- No. 3 JZZI Potential Catalyst - Signing Of LOI To Start New Business Venture JZZ Technologies, Inc. Joins with GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp. to Create New Bioscience Products Company Focused on Breakthrough Therapeutic Products and Research Working with respected bioscience companies GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp., JZZ Technologies, Inc. intends to launch a new bioscience products venture developing and marketing novel therapeutics utilizing natural compounds for age-related healthcare issues. Palm Beach, Florida--(Newsfile Corp. - November 16, 2021) - JZZ Technologies, Inc. (OTC Pink: JZZI) has signed a Letter Of Intent (LOI) to join with biotech company GenBio, Inc., and bioscience company Nutrific of Aliso Viejo, California, to create a new business venture in the Life Extension and Longevity sector. The new entity, which will operate under the NutraEdge Biosciences Corp. brand, contemplates utilizing product development, research, and existing human resources of GenBio, Inc., and Nutrific in its pursuit of therapeutics for various medical ailments and age-related health issues. Under the terms, JZZ Technologies, Inc. will acquire 100% ownership of NutraEdge Biosciences Corp. [...] Charles Cardona, CEO of JZZ Technologies, Inc., stated, "We are very excited to be working with the world-class team that GenBio, Inc., Nutrific, and NutraEdge Biosciences Corp. bring to the table. Our focus is acting as a platform to deliver products that can potentially improve life quality and contribute to human longevity. We are confident that the NutraEdge Biosciences venture will play an industry-leading role in this important space." [...] [Read the full article here.]( ----- No. 4 JZZI Potential Catalyst - Huge Revenue Projection Moving Forward JZZ Technologies, Inc. Projects Revenue of Over One Mn Dollars Per Month from its Recent Acquisition of Beacon Insurance Solutions Palm Beach, Florida, Oct. 06, 2021 (GLOBE NEWSWIRE) -- With the acquisition by JZZ Technologies, Inc. (OTC Pink: JZZI) of Beacon Insurance Solutions Inc. now completed, there is a very positive outlook among both businesses toward generating significant growth in short-term revenue that is expected to quickly reach the one Mn dollars per month figure. [...] Charles Cardona, the visionary CEO and Founder of JZZ Technologies, Inc. added insight into the business developments stating, “While the margins for the insurance industry may not be as glamorous as the high-tech sector at the 10% to 12% range, the stability and predictability of the revenue streams will more than compensate for that.” “The insurance business is the industry that Warren Buffett used as the catalyst to provide stability and a continuously increasing inflow of cash for his other acquisitions for Berkshire Hathaway to build an enormous amount of wealth for shareholders," Cardona adds. “We expect that the stability of the revenue streams from our insurance subsidiary will be a perfect complement to the higher margins of the technology side of JZZ Technologies, Inc. as we begin producing revenue from our marketing database, which has recently been valued at over $13.1Mn by a verified third-party expert in the field.” [Read the full article here.]( ----- No. 5 JZZI Potential Catalyst - Another Low Float Idea According to the [OTC Markets website]( (as of 9/30/14), JZZI has a low float. The website reports this profile to have approximately 6.03Mn shares in its float. Why is that important? It's important on one crucial level. Volatility. With so few shares available for trading, other potential catalysts could help spark a vertical move in the short-term. ----- Recap: 5 Potential Catalysts For New Breakout Idea (JZZI) No. 1 - Advancing Research Through Anticipated Venture No. 2 - Huge Acquisition Related News Could Become Game-Changer No. 3 - Signing Of LOI To Start New Business Venture No. 4 - Huge Revenue Projection Moving Forward No. 5 - Another Low Float Idea ----- Coverage is officially initiated on JZZI. When you have time later, do this: Get JZZI on your radar now. Sincerely, FierceAnalyst | Jaks Swift Editorial Writer [Source]( Fierce | 539 W Commerce St, Dallas, TX 75208 [Unsubscribe {EMAIL}]( [Update Profile]( | [Constant Contact Data Notice]( Sent by jaks@fierceanalyst.net